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Tyrosine kinase receptorsIn a bioinformatics-based screen for cellular genes that enhance Zaire ebolavirus (ZEBOV) transduction, AXL
mRNA expression strongly correlated with ZEBOV infection. A series of cell lines and primary cells were
identiﬁed that require Axl for optimal ZEBOV entry. Using one of these cell lines, we identiﬁed ZEBOV entry
events that are Axl-dependent. Interactions between ZEBOV-GP and the Axl ectodomain were not detected in
immunoprecipitations and reduction of surface-expressed Axl by RNAi did not alter ZEBOV-GP binding,
providing evidence that Axl does not serve as a receptor for the virus. However, RNAi knock down of Axl
reduced ZEBOV pseudovirion internalization and α-Axl antisera inhibited pseudovirion fusion with cellular
membranes. Consistent with the importance of Axl for ZEBOV transduction, Axl transiently co-localized on the
surface of cells with ZEBOV virus particles and was internalized during virion transduction. In total, these
ﬁndings indicate that endosomal uptake of ﬁloviruses is facilitated by Axl.g, Department ofMicrobiology,
335 9006.
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The ﬁloviruses Ebolavirus andMarburgvirus have caused a number
of devastating hemorrhagic fever outbreaks in Africa over the past 30
years. These enveloped, non-segmented, negative-stranded RNA
viruses are listed as Category A biodefense agents due to the
signiﬁcantmortality associatedwith infection. No vaccines or antiviral
therapies are currently available against these viruses. A better
understanding of the cellular proteins that are required for ﬁlovirus
entry into cells may lead to strategies to combat these pathogens.
The Zaire ebolavirus (ZEBOV) and Lake Victoria marburgvirus
(MARV) glycoproteins (GP) facilitate pseudovirus entry into a broad
range of cell types from many mammalian species (Wool-Lewis and
Bates, 1998). This wide tropism has complicated the identiﬁcation of
cellular proteins required for ﬁlovirus entry. Nonetheless, several
different plasma membrane-associated proteins have been identiﬁed
to enhance ﬁlovirus infection/transduction. The C-type lectins have
been shown to increase entry into some cells (Alvarez et al., 2002;Baribaud et al., 2002; Geijtenbeek and van Kooyk, 2003; Lasala et al.,
2003; Lin et al., 2003;Marzi et al., 2004; Simmons et al., 2003a; Takada
et al., 2004), but many highly permissive cells do not contain C type
lectins leading investigators to conclude that this group of plasma
membrane-associated proteins serve as adherence factors rather than
receptors that mediate virus entry. Folate receptor-αwas identiﬁed to
enhance ZEBOV-GP pseudovirion entry when the protein was
ectopically expressed in Jurkat cells (Chan et al., 2001); however,
this protein was subsequently shown to be unnecessary in a number
of permissive cells (Simmons et al., 2003b; Sinn et al., 2003). Most
recently, the tyrosine kinase receptor Axl was identiﬁed to facilitate
ZEBOV and MARV transduction of some but not all permissive cell
lines (Shimojima et al., 2007; Shimojima et al., 2006).
Axl is one of three members of the TAM (Tyro3, Axl, Mer) protein
family (Linger et al., 2008). These proteins are single pass, type 1
plasma membrane-associated proteins. The ectodomain consists of
two immunoglobulin-like domains as well as and two ﬁbronectin-like
domains (Linger et al., 2008). The two immunoglobulin-like domains
are responsible for TAM family interactions with three known ligands
or groups of ligands, the Tubby family of proteins, Gas6 and Protein S
(Caberoy et al., 2010; Heiring et al., 2004; Sasaki et al., 2006; Stitt et al.,
1995; Varnum et al., 1995). These ligand/Axl interactions lead to
receptor homo- and heterodimerization of Axl, Mer and Tyro3 and
subsequent tyrosine-dependent signaling. Speciﬁcally, Gas6/Axl liga-
tion results in a variety of cell type-dependent effects including cell
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adhesion (McCloskey et al., 1997), cell survival (Zheng et al., 2009)
and division (Lee et al., 1999).
While no direct interactions between ZEBOV-GP pseudovirions
and Axl have been demonstrated, site-directed mutagenesis of Axl
identiﬁed residues in both the ectodomain and the cytoplasmic tail
that are required for enhanced ZEBOV-GP pseudovirion transduction
(Shimojima et al., 2007). The requirement of Axl cytoplasmic tail
residues suggests Axl signaling may be involved in Axl-dependent
ZEBOV-GP transduction.We recently demonstrated that Axl enhances
bulk ﬂuid phase uptake or macropinocytosis of cargo as diverse as 70
kDa dextran, ZEBOV-GP pseudovirions, ZEBOV virus-like particles
(VLPs) and infectious ZEBOV. Axl-dependent macropinocytosis
required actin polymerization and was profoundly inhibited by the
amiloride analog EIPA (Hunt et al., 2011).
In a large screen of human tumor cell lines that correlated cellular
gene expressionwith ZEBOV-GP pseudovirion transduction, we found
that Axl expression positively correlated with ZEBOV-GP-dependent
transduction, but not vesicular stomatitis virus (VSV)-G-dependent.
To better understand the role of Axl in ﬁlovirus entry, we identiﬁed
steps involved with ZEBOV-GP-dependent transduction that require
Axl expression. Our ﬁndings indicate that Axl does not directly
interact with ZEBOV-GP but instead facilitates ﬁlovirus internalization
andmembrane fusion, consistent with a newly appreciated role of Axl
in macropinocytosis.
Results
AXL mRNA expression correlates with ZEBOV-GP-mediated transduction
of the NCI-60 panel of human tumor cells
To identify proteins important for ZEBOV-GP-mediated entry, we
performed Gene Correlation Analyses (CGA) using the NCI-60 panel of
human tumor cells. CGA screens have previously identiﬁed cellular
receptors for adeno associated virus 5 and 6 and implicated the GTPase
RhoC with enhancing both ZEBOV and VSV transduction (Di Pasquale
et al., 2003; Quinn et al., 2009;Weller et al., 2010). This bioinformatics-
based approach correlated virus transduction with gene expression in
the NCI-60 cell panel. VSV/EGFP virions pseudotypedwith eithermucin
domain deleted ZEBOV glycoprotein (ZEBOV-GP ΔO VSV) or VSV-G
(VSV-GVSV)were transduced into 52 of theNCI-60cell lines. ZEBOV-GP
ΔO that has the mucin domain of the glycoprotein deleted was used in
this screen and most of the other experiments in this study because it
contains the intact viral glycoprotein receptor binding domain, confers
entry in a manner similar to the full-length glycoprotein but produces
titers that are consistently higher (Jeffers et al., 2002).
The relative mean transduction values of three independent
experiments were used as a seed ﬁle and compared with gene array
data from the NCI-60 panel that is publically available at http://www.
dtp.nci.nih.gov/compare/. Using a Pearson correlation analysis, a list of
cellular genes that strongly and positively correlated with ZEBOV-GP-
dependent transduction was generated. Those cellular genes whose
expressionwere associatedwith ZEBOV-GPΔOVSV transductionwith a
highly positive Pearson correlation coefﬁcient (PCC) were further
delimited using EnTuned software to identify function, subcellular
location, and pathway associations since we were interested in genes
that expressed plasma membrane-associated proteins (http://www.
macresearch.org/entuned_pl). Additionally, genes that highly correlat-
ed with transduction of both ZEBOV-GP and VSV-G pseudovirions were
discarded under the assumption that these genes encoded proteins
involved in VSV uncoating and/or expression and were not genes
directly pertinent to ZEBOV-GP-dependent entry.
A number of geneswere identiﬁed that encoded plasmamembrane-
associated proteins that correlated with ZEBOV-GP pseudovirion
transduction but did not correlate with VSV-G pseudovirion transduc-
tion. Expression of one gene that correlated stronglywas the Tyro3/Axl/Mer (TAM) family member AXL (Fig. 1A). ZEBOV-GP-dependent
transduction of the cell panel, but not VSV-G-dependent transduction
demonstrated a similar trend to that observed with AXL mRNA
expression (Fig. 1B and C). AXL mRNA expression in the NCI-60 panel
correlated with ZEBOV-GP-mediated transduction with a PCC of 0.517
that was found to be highly statistically signiﬁcant (pb0.001). Axl had
been previously identiﬁed to facilitate ﬁlovirus entry in a cDNA screen
performed by Shimojima et al.(2006). While Shimojima et al.
demonstrated that the other two TAM family members Dtk (also called
Tyro3) and Mer can also enhance ZEBOV-GP-dependent transduction
into poorly permissive cells (Shimojima et al., 2006), neither Tyro3 nor
Mer positively correlated with ZEBOV-GP-dependent transduction in
our screen. Interestingly, folate receptor-α that is implicated in ﬁlovirus
entry did not correlate with ZEBOV-GP-dependent transduction in this
screen.
To validate the NCI-60 microarray correlation ﬁndings, we initially
evaluated cell surface expression of Axl on two of the cell lines
identiﬁed by the gene array to have high AXL mRNA expression and
two lines with low AXL mRNA expression. Axl protein expression
levels as assessed by binding of polyclonal antisera directed against
the Axl ectodomain to live cells in a ﬂow cytometric assay were
consistent with the microarray data. M14 and UACC-257 (#3 and #7
melanoma lines in Fig. 1, respectively) that had little or no AXLmRNA
expression did not have detectable Axl on their surface (Fig. 2A). In
contrast, SNB-19 and SN12C (#4 CNS line and #6 renal line in Fig. 1)
that had abundant AXLmRNA expression in the gene array expressed
large quantities of cell surface Axl (Fig. 2B). Evaluation of Axl surface
expression on other NCI-60 lines was also consistent with the gene
array results (data not shown). To further appraise Axl expression on
primary cell populations, human foreskin ﬁbroblasts (Hff) and human
umbilical vein endothelial cells (HuVEC) were examined and found to
express readily detectable levels of cell surface Axl (Fig. 2C). These
same six cell populations were also assessed for both Tyro3 and Mer
expression and none of themwas found to express the other two TAM
family members (data not shown).Axl enhancement of ZEBOV-GP-mediated infection is cell type-speciﬁc
To examine the requirement for Axl in ZEBOV-GP-mediated entry,
we utilized polyclonal antisera directed against the Axl ectodomain that
has been shown to inhibit ZEBOV-GP-dependent transduction in some
cells (Shimojimaet al., 2006). VSV-Gpseudovirions served as controls in
these studies since Axl expression did not positively correlatewith VSV-
G-dependent transduction in our CGA.WeusedVero and 293T cells that
do not require Axl expression for optimal ZEBOV pseudovirion
transduction as negative controls in this study (Shimojima et al.,
2006). As previously demonstrated (Shimojima et al., 2006), we found
that 293T cells do not express Axl,whereasVero cells express signiﬁcant
levels of surface Axl, but Axl expression has no effect on ZEBOV
transduction (data not shown). In addition to transducing these cells,
we extended our studies to include two Axl-expressing lines from the
NCI-60 panel as well as our Axl-expressing primary cells (Hffs and
HuVECs). Cells were incubated with Axl antisera or normal goat sera
(GS) and transduced with equivalent amounts of ZEBOV-GP ΔO or
VSV-GVSVpseudovirions. Axl antisera signiﬁcantly reduced ZEBOV-GP-
dependent transduction of SNB-19, Hff, and HuVECs, but did not
decrease transduction of 293T, Vero or SN12C cells (Fig. 3A). Thus,
ZEBOV transductionwas enhanced by surface availability of Axl in three
of the Axl-expressing cell populations. Additionally, our ﬁndings with
Vero and SN12C cells are consistent with the previous report that
surface Axl expression does not predict that Axl will facilitate ZEBOV-
GP-dependent uptake (Shimojima et al., 2006). Similar ﬁndings using
Axl antisera incubated with these different cell populations were also
observed with FIV pseudovirions bearing ZEBOV-GP (data not shown).
This highlights the fact that the effect of Axl on ZEBOV transductionwas
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Fig. 1. Correlation of ZEBOV-GP pseudotyped VSV transduction with AXL expression in the NCI-60 panel of human tumor cells. (A) Relative expression of AXLmRNA expression in the
52 cell lines analyzed in the screen. (B) ZEBOV-GP ΔO VSV transduction of the 52 lines. (C) VSV-G VSV transduction of the same lines. AXL expression and ZEBOV-GP ΔO-dependent
transduction, but not VSV-G-dependent transduction were positively correlated in our transduction screen with a Pearson correlation coefﬁcient (PCC) of 0.517 (pb0.0001). Data
shown are themean of three independent sets of transductions. Gene array data from the individual arrays are available at http://www.dtp.nci.nih.gov/mtargets/download.html. The
data set compared in this study was GC11900. Leuk=leukemia lines; NSCLC=non-small cell lung carcinoma; CNS=central nervous system; P=prostate.
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Fig. 2. Cell surface Axl expression. (A) Axl surface expression on two NCI-60 cell lines
that were poorly transduced with ZEBOV-GP ΔO VSV and displayed low levels of AXL
expression in NCI-60 gene array studies. (B) Axl surface expression on two NCI-60 cell
lines that were highly transduced with ZEBOV-GP ΔO VSV and displayed robust levels
of AXL mRNA expression on the gene arrays. (C) Axl expression on the surface of two
primary human cell populations, human foreskin ﬁbroblasts (Hff) and umbilical cord
endothelial cells (HuVEC). Cells stained with normal goat sera are shown in gray
histograms, whereas cells stained with goat anti-human Axl antisera are shown in black
histograms.
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ﬁnding, we used both VSV and FIV pseudovirions in this study.
Surprisingly, we found that VSV-G transduction into SN12C, Hffs
and HuVECS was decreased by Axl antibodies. SNB-19 cells that had
reduced ZEBOV-GP-dependent entry in the presence of Axl antisera did
not have reduced VSV-G transduction in the presence of the antisera.
This ﬁnding is consistent with our previously published studies using
RNAi knock down of Axl (Hunt et al., 2011). Interestingly, both ZEBOV-
GP- and VSV-G-dependent entry were inhibited by anti-Axl antibodies
in the primary cell populations.
Enhancement of ZEBOV transduction by surface expression of Axl
We recently showed that RNAi knock down of endogenous AXL
expression reduced replication of infectious ZEBOVby80%during a 20 h
virus infection, directly demonstrating the importanceofAxl for optimal
ZEBOV entry into some cells (Hunt et al., 2011). As these initial studies
only evaluated ZEBOV infection during a single round of infection, we
sought to determine if Axl antisera effectively decreased ZEBOV
infection over a longer term infection. In these studies, a recombinant,
infectious VSVwas generated that has the G gene replacedwith ZEBOV-
GP ΔO and EGFP (ZEBOV-GP-VSV/EGFP) that allowed us to assess virus
replication under BSL2 conditions. These studies were performed in
SNB-19 cells that are part of the NCI-60 panel (CNS cell line #4, Fig. 1)
and served as a model cell type that requires Axl for optimal ZEBOV-GP
transduction, but not VSV-G transduction. These cells express large
quantities of Axl and can be readily transfected, providing an excellent
cell line for understanding the role of Axl in ZEBOV infection. Axl
antisera or GS was added 15min prior to the addition of infectious
ZEBOV-GP-VSV/EGFP (MOI=0.1). EGFP positive cells in the cultures
were assessed by ﬂow cytometry at days 1–4 of infection. Axl antisera
decreased the number of VSV infected cells at days 2 and 3, indicating
reduced levels of initial infection and delayed spread of the virus
(Fig. 3B). Thus, consistent with our earlier study (Hunt et al., 2011), loss
of Axl availability on the surface of SNB-19 cells using Axl antisera also
inhibits ZEBOV-GP-dependent infection.
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Fig. 3. The impact of Axl on ZEBOV transduction is cell dependent. (A) Ability of Axl antisera to block ZEBOV-GP- and VSV-G-dependent transduction. Cells were incubated with 8 μg/
ml of goat anti-Axl sera or normal goat serum (GS) at 4 °C for 30 min. VSV-G or ZEBOV-GP ΔO pseudotyped VSV (MOI=0.5) was added to cells and shifted to 37 °C. Twenty hours
following transduction, the cells were analyzed for EGFP expression using ﬂow cytometry. Relative transduction values in the presence of antisera are shown as the percent of
transduction in the absence of antisera (control values) for each cell population. Shown are the mean and standard error of the mean of three independent experiments. *pb0.05,
**pb0.001. (B) Ability of Axl antisera to reduce infection of recombinant ZEBOV-GP ΔO VSV. SNB-19 cells were pre-incubated with either 2 μg/ml of anti-Axl antisera or normal goat
sera (GS) for 15 min prior to addition of virus (MOI=0.1). Cells were assessed for EGFP expression on days noted. Shown are the mean and standard error of the mean of one
experiment that is representative of three independent studies that were performed. (C) Ability of Axl expression to increase ZEBOV-GP ΔO pseudotyped VSV entry in the poorly
permissive NCI-H522 cell line. NCI-H522 cells were transfected with empty plasmid or plasmid expressing Axl and transduced with VSV pseudotypes (MOI 0.005) 48 h following
transfection. Cells were analyzed for EGFP expression 24 h following transduction by ﬂow cytometry. A ratio of transduction in the presence of Axl expression plasmid relative to
transduction in the presence of empty plasmid is shown. Shown are the mean and standard error of the mean of three independent experiments. **pb0.001.
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TAM family members enhanced the entry of ZEBOV into cells that
were normally not permissive to ZEBOV (Shimojima et al., 2006). We
thus sought to determine if expression of Axl could enhance ZEBOV-
GP-mediated entry into additional cell populations identiﬁed in our
current CGA screen as low AXL mRNA expressers and poorly
permissive for ZEBOV transduction. We transfected two NCI-60
NSCLC populations, NCI-H460 and NCI-H522 (NSCLC cell lines #8
and 9, respectively, Fig. 1), with an empty expression vector or with
an expression vector bearing Axl (Fig. 3C). Flow cytometric analysis of
the transfected cells demonstrated cell surface expression of Axl in the
Axl plasmid transfected populations (data not shown). Cells were
transduced with ZEBOV-GP ΔO or VSV-G VSV (MOI=0.005) at 48 h
following transfection. The ratio of transduction in the presence of
empty plasmid versus the Axl-expressing vector was then calculated
after live cell assessment for EGFP by ﬂow cytometry. A 3.5 fold
increase in ZEBOV-GP-mediated transduction was observed in the
NCI-H522 cells (Fig. 3C) whereas a more modest 1.7 fold increase was
observed in NCI-H460 cells (data not shown). Transduction ratios of
VSV-G VSV remained unchanged in both cell populations, indicating
that transient expression of Axl in cells that do not normally express
abundant levels of Axl allows for a speciﬁc enhancement of ZEBOV-
GP-mediated entry.
Transduction of proteolytically processed ZEBOV pseudovirion requires
Axl
Proteolytic processing of ZEBOV-GP1 is required for virion fusion to
occur (Chandran et al., 2005; Schornberg et al., 2006). We inquired ifthe requirement for Axl for optimal ZEBOV transduction into SNB-19
cells was affected by proteolytic processing of ZEBOV-GP pseudovirions.
We transfected SNB-19 cells with either AXL RNAi or an irrelevant RNAi
and transduced either full-length or thermolysin-treated full-length
ZEBOV-GP VSV into the transfected cells. The ZEBOV-GP on virions
mock or thermolysin-treated was immunoblotted to verify protease
cleavage of the viral GP (Supplemental Fig. 1). AXL RNAi decreased the
total amount of Axl protein present in SNB-19 cell lysates and reduced
Axl on the surface of cells (Fig. 4A and B). As previously observed by
others (Schornberg et al., 2006), thermolysin-treated virions had about
4-fold higher transduction than virions pseudotyped with untreated,
full-length ZEBOV-GP. However, transduction into AXL RNAi-treated
cells of either untreated or thermolysin-treated virions was reduced by
approximately 55% indicating that the thermolysin-treated virions still
required Axl for optimal transduction into SNB-19 cells (Fig. 4C).
ZEBOV-GP does not interact with the Axl ectodomain
Evidence demonstrated a requirement for Axl in some cells for
optimal ﬁlovirus transduction, but direct interaction of ZEBOV-GP and
Axl has not been shown. Co-immunoprecipitations (co-IPs) between
Axl and ZEBOV-GP were performed to determine if we could detect
direct interactions between the two proteins. The chimeric protein
Axl-Fc was bound to Protein A beads and incubated with ZEBOV-GP
ΔO pseudotyped FIV, baculovirus GP64 pseudotyped FIV or the
endogenous Axl ligand Gas6. Neither of the two viral glycoproteins
interacted with Axl-Fc (Fig. 5A); however, Gas6 bound to Axl-Fc
indicating the immunoprecipitation conditions were appropriate for
detection of ligand–receptor interactions.
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Fig. 4. Thermolysin-treated ZEBOV-GP pseudovirions remain sensitive to AXL RNAi treatment. (A and B) Knockdown of Axl expression in SNB-19 cells by validated AXL siRNA
(Invitrogen) at 48 h following transfection as assessed by immunoblotting of cell lysates for Axl (A) or cell-surface expression of Axl (B). Shown in the black histogram are cells
treated with AXL RNAi; the gray histogram represents cells treated with an irrelevant RNAi. (C) Thermolysin-treated full-length ZEBOV-GP FIV pseudovirions remain sensitive to AXL
RNAi treatment. Virions were treated with thermolysin or mock-treated and added to SNB-19 cells that were treated with either AXL RNAi or an irrelevant RNAi. Cells were evaluated
at 48 h following transduction for β-gal expression. The ﬁndings are shown as the number of transduced cells found in each treatment divided by the number of cells transduced by
the untreated full-length ZEBOV-GP control. The numbers in parenthesis represent the effect of AXL RNAi treatment on transduction relative to the respective control. **pb0.001.
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co-IPs were repeated to determine if ZEBOV-GP pseudotyped virus
could pull-down Axl from SNB-19 cell lysates. ZEBOV-GP ΔO pseudo-
typed FIV particles were bound to beads using anti-GP1 antibodies.
SNB-19 cell lysates were incubated with the beads and bound proteins
were identiﬁed by immunoblotting. Again, ZEBOV-GP failed to pull-
down Axl from the cell lysates (Fig. 5B). As a cellular receptor for ZEBOV
has yet to be identiﬁed, wewere unable to provide a positive control for
ZEBOV-GP co-immunoprecipitations in this study.U   B  _ U   B  _ U   B  _
Axl-Fc IP
WB:   α ZEBOV-GP1     α GP64          α Gas6
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Fig. 5. Direct interactions between ZEBOV-GP and Axl cannot be detected. (A) Axl–Fc
(0.5 μg) was bound to Protein A sepharose beads and incubated with ZEBOV-GP ΔO or
baculovirus GP64 pseudotyped FIV particles. Pull-down of Gas6 (0.5 μg) served as a
positive control in this study. U, unbound; B, Axl–Fc bound. (B) ZEBOV pseudotyped
particleswere bound to proteinGbeadswith anti-ZEBOV-GP1 antisera. SNB-19 cell lysates
werepassed over the beads and the unbound (U),wash (W), and bound (B) fractionswere
examined for Axl by immunoblot. (C) Axl–Fc does not interact with thermolysin-cleaved
ZEBOV FIV particles.We also evaluated possible interactions of thermolysin-cleaved
ZEBOV-GPwith Axl. We veriﬁed that thermolysin treatment of virions
produced the 19 kDa GP1 product (Supplemental Fig. 1) and
evaluated viral particles for their ability to interact with Axl-Fc during
a co-IP (Fig. 5C). Pre-cleaved virions also failed to interact with Axl.
These studies provide a number of lines of evidence that ZEBOV-GP
and Axl do not interact under the conditions tested.
Loss of Axl does not affect ZEBOV pseudovirion binding to SNB-19 cells,
but decreases ZEBOV-GP pseudovirion internalization and fusion
We could not detect direct interactions between Axl and ZEBOV-
GP in pull downs; however, we also assessed Axl/ZEBOV-GP in-
teractions by evaluating if loss of cell surface availability of Axl
impacted ZEBOV-GP pseudovirion binding to SNB-19 cells. We ﬁrst
tested whether pre-incubation of commercially available, puriﬁed
Axl-Fc (R&D Systems) with SNB-19 or 293T cells reduced ZEBOV
transduction and found that this had no effect on transduction of
either ZEBOV-GP ΔO or VSV-G VSV pseudovirion transduction into
either cell type (Fig. 6A). In these studies, we used 293T cells as a
negative control since Axl is not expressed in these cells. AXL RNAi
knock down of Axl expression also had no effect on ZEBOV-GP ΔO FIV
pseudovirion binding to SNB-19 cells (Fig. 6B). Finally, pre-treatment
of SNB-19 cells with polyclonal Axl antisera did not reduce ZEBOV-GP
ΔO pseudovirion binding to cells (data not shown). In total, our data
provide no evidence that Axl directly interacts with ZEBOV-GP. Thus,
it is unlikely that Axl serves as a cellular receptor for this virus.
We also determined if RNAi knock down of AXL inhibited ZEBOV-
GP pseudovirion internalization. We treated cells with AXL RNAi or an
irrelevant RNAi (Block-It, Invitrogen) and, 48 h later, ZEBOV-GP ΔO or
VSV-G FIV pseudovirions were bound to SNB-19 cells for 1 h at 4 °C.
The cells were washed to remove unbound virus. Under these
conditions where no virions are internalized into cells, detection of
cell-bound virions was completely abrogated by trypsin treatment
(data not shown). Following a 2-h incubation of these virus-bound
cells at 37 °C, cells were treated with trypsin to remove any virions
that were not internalized, washed with PBS with 5% FCS and lysed.
Lysates were immunoblotted for FIV capsid and cellular actin and the
amount of each protein was quantiﬁed by ECL photon emission on the
immunoblot. Amount of internalized virus was normalized to cell
numbers using cellular actin signals. The data are shown as the
amount of internalized virions in the presence of AXL RNAi divided the
amount of internalized virions in cells treated with Block-It (Fig. 6C).
We found that ZEBOV-GP ΔO pseudovirion internalization was
reduced approximately 40% by AXL RNAi treatment. This provided
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Fig. 6. Axl is required for post-binding events. (A) Soluble Axl–Fc does not interfere
with ZEBOV-GP ΔO pseudotyped VSV transduction. ZEBOV and VSV-G virions were pre-
incubated with Axl–Fc (50 μg/ml) and transduced on to Axl-dependent SNB-19 cells or
the Axl-independent 293T cells. Transduction was evaluated by EGFP expression in the
transduced populations at 24 h. Results are shown as the number of cells transduced in
the presence of Axl–Fc divided by the number of transduced cells in the absence of
treatment. (B) RNAi knock down of Axl had no effect on ZEBOV-GP ΔO pseudovirion
binding. Forty-eight hours following transfection of AXL RNAi or an irrelevant RNAi into
SNB-19 cells, equivalent quantities of ZEBOV-GP ΔO FIV were incubated with cells for
1 h at 4 °C. Unbound virus was removed and cells were lysed. Lysates were
immunoblotted for FIV capsid and quantitated as described in Materials and methods.
Shown are average pixel values of FIV capsid on the immunoblot divided by the average
pixel values for cellular β-actin from 10 independent experiments. (C) ZEBOV-GP ΔO
FIV internalization, but not VSV-G FIV is decreased in AXL siRNA-treated cells. SNB-19
cells were transfectedwith AXL siRNA or an irrelevant control siRNA. At 48 h, ZEBOV-GP
ΔO FIV pseudovirions were bound to the cells for 1 h at 4 °C. Unbound virus was
removed and cells were shifted to 37 °C for 2 h. Cells were lysed and immunoblotted for
FIV capsid and cellular actin. The capsid signal was normalized for actin levels and data
are reported as the ratio of the FIV signal in the Axl knock down cells divided by the FIV
signal in the cells transfected with an irrelevant RNA. (D) Ability of Axl antisera to block
ZEBOV VLP fusion events. ZEBOV-GP ΔO VLPs containing Src-β-lactamase were
transduced into SNB-19 cells in the presence or absence of 1:20 dilution of polyclonal
antisera against the ectodomain of Axl or normal goat sera (NGS). Entry of β-lactamase
into the cytoplasm of cells was evaluated by ﬂow cytometry following incubation of the
cells with the ﬂuorescent β-lactamase substrate CCF2/AM for 2 h. *pb0.05.
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by Axl. Similar studies with VSV-G pseudovirions demonstrated that
Axl knock down had no effect on internalization of these virions.
To further explore the effect(s) of Axl on ZEBOV-GP-mediated
post-binding events, we assessed virion/endosomal membrane fusion
using ZEBOV-GP ΔO bearing virus-like particles (ZEBOV ΔO VLPs). As
virion fusion events are downstream from virion internalization
events, we predicted that Axl antisera would also reduce fusion.
ZEBOV ΔO VLPs were generated containing recombinant Src/β-
lactamase protein as previously described (Quinn et al., 2009) and
were used in these studies to complement our internalization ﬁndings
using FIV cores rather than ZEBOV cores. In this assay, β-lactamase
activity was detected by pre-loading the ﬂuorescent β-lactam
substrate CCF2/AM into the cytoplasm of SNB-19 cells. ZEBOV ΔO
VLP fusion with endosomal membranes was measured by a change in
ﬂuorescence due to cleavage of the β-lactam ring (Cavrois et al., 2002;
Cavrois et al., 2004). In a manner consistent with our FIV-based
internalization assays, the addition of anti-Axl antisera decreased
ZEBOV ΔO VLP fusion by about 40% compared to the normal GS
(Fig. 6D). Thus, both virus internalization and fusion were reduced bythe loss of available surface-expressed Axl, indicating that Axl is
involved in ZEBOV-GP-mediated entry at a post-binding step.
Axl internalizes as ZEBOV pseudovirions enter SNB-19 cells
To determine the localization of Axl during ZEBOV-GP ΔO pseudo-
virion entry, both pseudovirions and Axl were tracked in SNB-19 cells
over a 45-min time course of ZEBOV-GP ΔO FIV transduction using
confocal microscopy. Axl was found to be present primarily on the
surface of naive SNB-19 cells (data not shown). A similar distribution of
Axl was observed in cells that were cooled to 4 °C and incubated for
60 min with either ZEBOV-GP ΔO FIV (MOI=250) (Figs. 7A and 8A) or
FIV-VSV-G FIV (MOI=250) (Supplemental Fig. 2). A highMOIwas used
in these studies to allowgood confocal detection of virionsusing ananti-
FIV capsid antibody. Cell surface co-localization of ZEBOV pseudovirions
and Axl was evident during the initial 4 °C binding step in both
permeabilized and non-permeabilized cells (Figs. 7A and 8A). Following
this 1 h binding step, unboundviruswas removedand cellswere shifted
to 37 °C for various times (Figs. 7B–D and 8B–D). At 15 min following
the temperature shift, both Axl and ZEBOV-GP ΔO FIV pseudovirions
remained almost exclusively on the cell surface and frequent co-
localizationwas still observed. By 30 min, both virions andAxl appeared
to be internalized since decreased FIV capsid and Axl signals were
consistently observed in non-permeabilized cells (Fig. 8C) and, in the
permeabilized cells, expression of both antigens appeared distributed
throughout the cell (Fig. 7C). At 30–45 min, little co-localization of the
two signals occurred and, by 45 min, while much of the Axl remained
intracellular, a portion of Axl appeared to be surface expressed again,
suggesting the possibility that some was recycled to the surface of the
cells (Figs. 7D and 8D). Combined, these studies provide evidence of
internalization of both virions and Axl during virion infection, although
co-localization of the two signals within cells did not occur.
Parallel confocal microscopy studies were performed with SNB-19
cells incubated with FIV virions pseudotyped with no viral glycopro-
tein and FIV virions pseudotyped with VSV-G. Axl and non-enveloped
virions did not co-localize under these conditions at any time and, as
expected, were unable to enter the cells at any point (data not
shown). Surprisingly, we observed co-localization of VSV-G pseudo-
virions and Axl on the surface of cells at the zero time point. Much of
this co-localization of the two signals was lost by 15 min at 37 °C
(Supplementary Fig. 2). Unlike the ZEBOV-GP pseudovirion studies, as
virions became intracellular over the 45 min, a parallel internalization
of Axl was not observed. Instead, Axl remained primarily cell surface
associated, suggesting that Axl was not internalized with the VSV-G
pseudovirions.
Discussion
In a bioinformatics-based screen using a large panel of human tumor
cells, Axl expression strongly correlated with ZEBOV-GP pseudovirion
transduction. Axl was previously characterized to enhance ﬁlovirus
entry into some cell populations (Shimojima et al., 2006) and, in a
similar manner, we also observed that surface expression of Axl
enhances ZEBOV pseudovirion entry into some cells. Using multiple
approaches to inhibit Axl, we provided evidence that ZEBOV pseudovir-
ion internalization and subsequent fusion are inhibitedby loss of surface
Axl expression. The impact on virus internalization did not appear to be
due to direct Axl interaction with ZEBOV-GP pseudovirions or reduced
ability of ZEBOV pseudovirions to interact with permissive cells,
suggesting that Axl was stimulating ZEBOV-GP pseudovirion uptake
through indirect mechanisms rather than serving as a receptor for
ZEBOV. Consistent with a role for Axl in ZEBOV internalization, Axl and
virions concomitantly internalized during pseudovirion entry.
Both ZEBOV pseudovirion internalization and membrane fusion
were decreased by about 40% with the reduction of Axl on the surface
of SNB-19 cells as assessed by AXL RNAi and Axl-speciﬁc antisera using
FIV capsid MergeAxl
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Fig. 7. Axl transiently associated with ZEBOV-GP ΔO pseudovirions on the cell surface and was internalized as virions entered cells. Confocal microscopy of Axl and FIV capsid during
ZEBOV-GP ΔO FIV transduction. (A) Localization of Axl and FIV capsid expression in SNB-19 cells incubated with ZEBOV-GP ΔO FIV (MOI=250) for 1 h at 4 °C. (B–D) Localization of
Axl and FIV capsid in SNB-19 cells following incubation of ZEBOV-GP ΔO FIV (MOI=250) for 1 h at 4 °C, removal of unbound virions and incubation of cells with pre-warmed media
at 37 °C for 15 min (B), 30 min (C) or 45 min (D). All coverslips were ﬁxed with 2% paraformaldehyde, permeabilized with 0.2% Triton X-100 and immunostained with goat anti-Axl
and mouse anti-FIV capsid. Findings shown in panels are representative experiments performed three independent times.
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of these steps results in a similar level of inhibition, it is likely that the
effect occurs at the upstream event, internalization, and that fusion is
affected as a result of reduced internalization. The modest impact on
both of these entry events was associated with signiﬁcantly
decreased/delayed virus replication using a single administration of
Axl antisera prior to initiation of infection (Fig. 3B). It is surprising that
a 40% decrease in these entry events resulted in a complete loss of
detectable infection at 2 days following infection. One possible
explanation is that additional steps in virus replication that were
not evaluated in these studies are inhibited by loss of cell surface Axl
in addition to virus internalization.
We recently demonstrated that Axl stimulates bulk ﬂuid phase
uptake or macropinocytosis (Hunt et al., 2011). Loss of Axl-dependent
macropinocytic activity resulted in not only decreased uptake of
ZEBOV pseudovirions, but other cargos such as largemolecular weight
dextran. Thus, we propose that greater numbers of ZEBOV particles
bound to or in proximity with the surface of SNB-19 cells are
internalized into endosomes due to Axl-dependent macropinocytosis,
resulting in higher levels of virus infectivity. While our studies
indicated that Axl-dependent macropinocytosis is important for
enhanced ZEBOV entry (Hunt et al., 2011), the trigger(s) that
stimulate macropinocytosis have yet to be identiﬁed.Several lines of evidence suggest that cell signaling pathways
are activated during Axl-dependent enhancement of ZEBOV-GP-
mediated transduction. Shimojima et al. demonstrated that deletions
in the cytoplasmic tail of Axl reduced Axl-mediated enhancement of
ZEBOV-GP pseudovirion transduction, arguing that cell signaling is
critical for Axl-enhanced ZEBOV infection (Shimojima et al., 2007).
Our studies demonstrated that phospholipase C inhibitors speciﬁcally
inhibited ZEBOV pseudovirion transduction in Axl-dependent cells,
but not in cells where Axl does not enhance ZEBOV transduction
(Hunt et al., 2011).
Signaling through Axl activation has been almost exclusively
studied using the endogenous Axl ligand Gas6. Gas6 binding to Axl
leads to a variety of cell-dependent biological outcomes including
cytoskeleton rearrangements, cell migration, cell survival and division
(Demarchi et al., 2001; Goruppi et al., 2001; Goruppi et al., 1997, 1999;
Melaragno et al., 2004; Nielsen-Preiss et al., 2007; Zheng et al., 2009).
Prior to our study (Hunt et al., 2011), a role for Axl in macropinocytosis
had not been appreciated; however, TAM familymemberMer is known
to activate phagocytosis in macrophages (Scott et al., 2001; Shao et al.,
2009). While co-IPs have demonstrated that the phosphorylated
tyrosines in the cytoplasmic tail of TAM proteins interact with
p85alpha and p85beta subunits of PI3K, PLCγ, RanBPM, Grb2 and Src
(Braunger et al., 1997; Haﬁzi et al., 2005), Gas6/Axl interactions have
FIV capsid MergeAxl
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Fig. 8. Both Axl and ZEBOV-GPΔO pseudovirions are internalized from the cell surface during infection. Confocal microscopy of Axl and FIV capsid during ZEBOV-GPΔO FIV transduction
in non-permeabilized cells. (A) Localization of Axl and FIV capsid expression in SNB-19 cells incubated with ZEBOV-GP ΔO FIV (MOI=250) for 1 h at 4 °C. (B–D) Localization of Axl and
FIV capsid in SNB-19 cells following incubation of ZEBOV-GP ΔO FIV (MOI=250) for 1 h at 4 °C, removal of unbound virions and incubation of cells with pre-warmedmedia at 37 °C for
15 min (B), 30 min (C) or 45 min (D). All coverslips were ﬁxed with 2% paraformaldehyde and immunostained with goat anti-Axl and mouse anti-FIV capsid. Findings shown in panels
are representative experiments performed three independent times.
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(Demarchi et al., 2001; Goruppi et al., 2001; Goruppi et al., 1997, 1999;
Lee et al., 1999; Melaragno et al., 2004; Son et al., 2007; Weinger et al.,
2008; Wilhelm et al., 2008; Zheng et al., 2009). As stimulation of Axl-
dependent macropinocytosis that enhanced ZEBOV infection did
not require activation of the PI3K/Akt pathway, but phospholipase
C-dependent pathways (Hunt et al., 2011), Axl signaling appears to
occur through at least two different signaling pathways, leading to
different physiological consequences. Recently, a new group of ligands
for the TAM family kinases was identiﬁed (Caberoy et al., 2010). The
Tubby protein interacts only with Mer, whereas tubby-like protein1
(Tulp1) interacts with all three TAM family members. Tubby contains
elements that are essential for Mer binding, phosphorylation and
phagocytosis activation. Tulp1 contains all of these functional elements
as well, and is capable of binding to Axl in vitro. Additionally, activation
of PLCγ and PLCβ have been linked to Tubby protein activation (Carroll
et al., 2004). However, it is not clear whether Tulp1 binding to Axl
activates Axl signaling and is the ligand responsible for Axl-induced
macropinocytosis. Further, it is not known if Tulp1/Axl interactions lead
to PLC activation or whether other downstream signaling is activated
by this interaction. While it is enticing to speculate that Tulp1 may be
activating Axl and thereby stimulatingmacropinocytosis, this has yet to
be directly demonstrated.While recent studies suggest that a novel ligand may be
responsible for activating Axl-dependent macropinocytosis leading
to increased uptake of ZEBOV, an alternative Axl interaction may also
stimulate ZEBOV entry. The Axl ectodomain is known to hetero-
dimerize with IL-15-bound IL-15 receptor leading to active Axl
signaling (Budagian et al., 2005). Thus, it is also possible that
ZEBOV-GP may stimulate Axl signaling events as a result of binding
to a currently unidentiﬁed receptor that in turn heterodimerizes with
Axl. Such interactions may lead to activation of downstream signaling
pathways. Such amodel would also be consistent with a role for Axl in
ZEBOV virion internalization.
As Shimojima et al. have shown (Shimojima et al., 2006), we
observed that Axl enhances ZEBOV-GP-dependent transduction in
some cells, but not others. While some cells such as 293T cells do not
express Axl, other Axl-independent cells do express Axl, but
expression of the protein does not enhance ZEBOV entry. Cell lines
such as VeroE6 (Shimojima et al., 2006), Vero and SN12C express Axl
on their plasmamembrane, but Axl expression does not affect ZEBOV-
GP-dependent transduction of these cells. It is possible that pathways
connecting Axl to macropinocytosis may be disrupted in these
transformed cell lines. In contrast, other Axl-expressing cells such as
SNB-19 cells that have roughly equivalent levels of surface-expressed
Axl as SN12C cells have a strong dependence upon Axl for optimal
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ment for Axl in each permissive cell population needs to be
empirically determined. We also demonstrated here that in two
primary human cell populations (Hffs and HuVECs), optimal ZEBOV-
GP-mediated transduction requires Axl. These initial studies with
primary cell populations suggest the possibility that Axl may be
important for in vivo ﬁloviral infection and pathogenesis.
As proteolytic cleavage of ZEBOV-GP might abrogate the need for
Axl, we investigated the effect of thermolysin cleavage of GP1 on the
requirement of Axl (Fig. 4C). We found that while virions that were
protease pre-treated had higher levels of transduction, entry of these
particles was just as sensitive to the loss of Axl as particles containing
full-length ZEBOV-GP. Thus, we concluded that the requirement for
Axl is independent of requisite proteolytic pathways needed for
productive ZEBOV transduction.
In our initial assessment of ﬁlovirus transduction of Axl-expressing
cells, VSV-G pseudotyped virions were used as a negative control.
Unexpectedly, VSV-G-dependent entry into some cells was reduced
about two-fold by Axl antisera (Fig. 3A). This was a more modest
impact than that observed for ZEBOV-GP transduction, but statisti-
cally signiﬁcant. This ﬁnding provides additional evidence that the
involvement of Axl in ZEBOV-GP-mediated entry is likely to due to
indirect interactions with the virions rather than direct viral
glycoprotein/receptor interactions. Even more surprising was our
observation that some cells that required Axl for ZEBOV-GP-
dependent entry did not require it for VSV-G-dependent entry and,
conversely, other cell lines required Axl for VSV-G-dependent entry
but not uptake mediated by ZEBOV-GP. One possible explanation for
this ﬁnding is that uptake pathways utilized by these viruses may
differ in these various cells. As we have demonstrated that Axl
expression enhances macropinocytosis, but not other uptake path-
ways (Hunt, et al. 2011), we would propose that macropinocytosis
also mediates VSV-G-dependent uptake into some cells. Consistent
with the possibility, Bhattacharyya et al. demonstrated that VSV-G
entry into some cells does not utilize clathrin coated pits, an entry
pathway that has been well established for VSV-G entry into many
cells (Bhattacharyya et al., 2010). Of note, entry of both pseudovirions
into the primary cells, Hffs and HuVECs, was enhanced by Axl
expression. Therefore, further exploration of uptake mechanisms of
these viruses in other relevant primary cells such as macrophages and
dendritic cells is warranted.
Material and methods
Cell lines
Cell lines fromtheNCI-60panel (dtp.nci.nih.gov/docs/misc/common_
ﬁles/cell_list.html) were examined for their ability to support mucin
domain deleted ZEBOV-GP (ZEBOV-GP ΔO) pseudovirion transduction.
All NCI-60 cells were maintained in RPMI with 5% FCS and pen/strep.
Human umbilical vein endothelial (HuVEC) cells were isolated from a
fresh umbilical cord and maintained in EBM media (Lonza/Cambrex)
supplementedwith the EBMbullet kit. Human foreskin ﬁbroblasts (Hffs)
(ATCC, CRL-1635) were grown in DMEMwith 15% FCS and pen/strep.
Antibodies and Fc molecules
Antibodies were purchased commercially when possible. These
included goat anti-Axl (#AF154, R&D Systems), mouse anti-FIV capsid
monoclonal antibody (NIAID AIDS Research and Reference Reagent
Program), feline anti-FIV polyclonal antibody (obtained locally from
FIV seropositive cats), mouse anti-baculovirus gp64 monoclonal
antibody (14-6995-81; eBioscience), mouse anti-human β-actin
(ab49900-100; Abcam). Rabbit anti-ZEBOV-GP1 was kindly provided
by A. Sanchez, CDC. Axl-human Fc (Axl amino acids 33–440 attached
to human Fc) was purchased from R&D Systems (#154AL).Pseudotyped particles
Pseudotyped VSV particles
Production of vesicular stomatitis virus (VSV) particles that were
pseudotyped with either ZEBOV-GP ΔO or VSV-G was performed as
previously described (Takada et al., 1997). Brieﬂy, 293T cells were
seeded into 15 cm dishes. The following day 75 μg of the glycoprotein
expression plasmid were transfected into the cells using calcium
phosphate transfection as previously described (Brindley et al., 2007).
Twenty-four hours following transfection, the cells were washed
twice in PBS and transfected 293Ts were transduced with pseudo-
typed VSV/EGFP/ΔG that expresses EGFP in place of the G glycopro-
tein at an MOI of 5. Six hours after transduction, the virus inoculum
was removed and cells were again washedwith PBS. Cell supernatants
were collected at 24, 36, and 48 h following transduction. Stocks were
ﬁltered, aliquoted, and stored at −80 °C until use.
FIV pseudotyped particles
Pseudotyped FIV viral particles were produced as previously
described (Brindley et al., 2007; Sinn et al., 2003). 293T cells were
transfected with a total of 75 μg of DNA consisting of plasmids
expressing one of three glycoproteins (full-length ZEBOV-GP, ZEBOV-
GP ΔO or VSV-G), a FIV gag-pol expressing construct (pFIVΔΔ), and a
packageable FIV genome that expressed β-galactosidase (pFIVψβgal) at
a ratio of 1:2:3, respectively. The DNAwas transfected into 15 cmdishes
of 293T cells using calcium phosphate transfection. Supernatants were
collected at 24, 36, 48, 60 and 72 h following transfection. The
supernatants were ﬁltered through a 0.45 μ ﬁlter and pelleted by an
overnight centrifugation step (7000 rpm4 °C in a Beckman JA-10 rotor).
The viral pellet was resuspended in DMEM for an approximate 200 fold
concentration. The virus was either used immediately for transduction
or stored at−80 °C until use.
ZEBOV VLPs
Src-β-lactamase incorporatedmucin domain deleted ZEBOV virus-
like particles (ZEBOV ΔO-VLPs) were produced by transfecting 293T
cells grown in 15 cm dishes with 75 μg of total DNA at a ratio of
1:2:3:3 for plasmids expressing ZEBOV-NP, ZEBOV-VP40, ZEBOV-GP
ΔO and src-β-lactamase fusion protein (Quinn et al., 2009). pNP and
pVP40 were kind gifts from Dr. Ronald Harty (University of
Pennsylvania). Supernatants were collected at 24, 36, 48, 60 and 72
h following transfection. The supernatants were ﬁltered through a
0.45 μ ﬁlter and pelleted by an overnight centrifugation step (7000
rpm 4 °C in a Beckman JA-10 rotor). The viral pellet was resuspended
in DMEM for an approximate 200 fold concentration. The virus was
stored at −80 °C until use.
NCI-60 screen
4×104 cells of 52 cell lines used from theNCI-60panel (http://www.
dtp.nci.nih.gov/docs/misc/common_ﬁles/cell_list.html) were plated in
48-well plates. Relative transduction efﬁciency was measured using
VSV/EGFP/ΔG particles pseudotyped with either VSV-G or ZEBOV-GP
ΔO. Twenty h following transduction the cells were evaluated for EGFP
expression by ﬂow cytometry to obtain the transduction efﬁciency for
each cell line. The average of a total of six transduction trials was used as
the seed ﬁle for COMPARE analysis against the GC235133 gene array
data set that used the Affymetrix U133A chip (dtp.nci.nih.gov/docs/
misc/common_ﬁles/cell_list.html).
Flow cytometry
EGFP expression
Twenty h following transduction, cells were lifted in 150 μl of
Accumax (Fisher Scientiﬁc) and analyzed with a FACScan ﬂow
cytometer (Becton Dickinson) for FL-1 intensity.
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Cells were lifted with PBS and 5 mM EDTA and washed 3 times in
PBS/5% FCS. Cells were incubated with goat anti-Axl (4 μg/ml) or
normal goat sera for 1 h on ice. Cells were washed and incubated with
Cy5-conjugated donkey anti-goat (1:50) (Jackson Immunoresearch)
for 30 min on ice. Cells were washed and analyzed a with FACScan
ﬂow cytometer for FL-4 intensity.
Competition assays
Antibody competition
4×104 cells were plated in 48-well plates. The cells were incubated
with polyclonal goat antisera (8 μg/ml) against the Axl ectodomain or
normal goat serum at 4 °C for 30 min. Pseudotyped VSV/EGFP/ΔG
particles (MOI=0.5) were added to the cells and the plate was shifted
to 37 °C to promote transduction. Twenty h following transduction, the
cells were lifted in Accumax (Fisher Scientiﬁc) and analyzed for EGFP
expression using ﬂow cytometry. The percentage of EGFP positive cells
was compared to control cells transduced without antisera added.
Axl–Fc competition
VSV/EGFP/ΔG particles pseudotyped with either ZEBOV-GP ΔO or
VSV-G were incubated with chimeric Axl ectodomain–Fc protein
(Axl–Fc) (R&D Systems) (50 μg/ml) for 30 min at 4 °C. The mixture
was transduced on to SNB-19 or 293T cells in a 48-well plate. Twenty-
four h following transduction, cells were analyzed for EGFP expression
using ﬂow cytometry.
Generation of infectious, recombinant ZEBOV-GP ΔO VSV
A molecular clone of VSV containing EGFP in place of G that was
generatedbyDr. JackRose (Haglund et al., 2000)waskindly providedby
Dr. Ira Bergman (University of Pittsburgh). The EGFP gene was inserted
in place of VSV-G (Gao et al., 2006) and ZEBOV-GP ΔO was inserted
upstream fromEGFP. The construct alongwith plasmids expressingVSV
N, P, M and L was transfected into BHK 21 cells as previously described
(Haglund et al., 2000; Lawson et al., 1995). The full-length genome and
each of the cDNAs were expressed from a T7 promoter sequence by
infection of the cells with vTF7-3, a recombinant vaccinia virus
expressing the T7 RNA polymerase. Supernatant was collected, ﬁltered
through a 0.2-μﬁlter and the viruswasplaque puriﬁed. Immunoblotting
of virus stocks veriﬁed expression of ZEBOV-GP. Stocks were titered by
end point dilution on Vero cells.
Immunoblotting
Axl was detected using a goat polyclonal anti-Axl sera (0.2 μg/ml).
Blots werewashed and incubatedwith corresponding secondary HRP-
conjugated sera.
AXL RNAi transfections
Two validated AXL RNAi constructs were purchased from Invitro-
gen along with an irrelevant control (Block-It). SNB-19 cells were
transfected with 200 pmol of the RNAi using Lipofectamine 2000
(Invitrogen). Twenty-four h following transfection, the cells were
lifted with trypsin and distributed into 48-well plates. For all RNAi
knock-down experiments, cells were examined for Axl protein
expression by immunoblotting and for Axl surface expression by
ﬂow cytometry at 48 h. We routinely observed a greater than 90% loss
of Axl surface expression and a similar reduction in total Axl
expression in cell lysates. In parallel, transfected cells that had been
veriﬁed for Axl knock down were transduced with FIV particles
bearing ZEBOV-GP ΔO FIV/β-galactosidase or VSV-G FIV/ β-galacto-
sidase and assayed for transduction as described above.Transfection of cells with Axl expression plasmid
An expression plasmid bearing Axl was obtained from the Gene
Transfer and Vector Core at the University of Iowa. NCI-H460 and NCI-
H522 cells were transfected with 4 μg of the Axl expression plasmid or
an equivalent empty plasmid using Lipofectamine 2000. Twenty-four
h following transfection, the cells were lifted with trypsin and
distributed into 48-well plates. Cells were examined for Axl surface
expression by ﬂow cytometry at 48 h. In parallel, transfected cells
were transduced with ZEBOV-GPΔO or VSV-G VSV pseudovirions and
assayed for transduction by ﬂow cytometry for EGFP expression as
described above.
Virus internalization assay
SNB-19 cells seeded in a six-well plate at a concentration of 5×105
cells per well were transfected with 200 pmol of AXL RNAi (described
above) or an irrelevant control RNAi (Block-It, Invitrogen) using
Lipofectamine 2000. Twenty-four h after transfection, cells were lifted
and replated in a 96-well plate at a concentration of 4×104 cells per
well. The following day, 20 μl of media (containing 10% FBS, 1% P/S
and ZEBOV-GPΔO FIV or VSV-G FIV) were incubatedwith eachwell of
cells for 1 h at 4 °C. After 1 h, media was removed and cells were
washed once with 100 μl sterile PBS and 100 μl of pre-warmed media
was added to each well for 1 h at 37 °C. At the termination of the
experiment, media was removed. Cells were lifted and extracellular
virus removed with a 5 min incubation with 100 μl of 0.25% trypsin/5
mM EDTA treatment. Trypsin/EDTA was neutralized with DMEMwith
FCS, and the cells were pelleted in a microcentrifuge for 4 min at
14,000 rpm. Supernatants were removed, and the pellet was lysed in
25 μl of sterile PBS containing 1% SDS. As a control, after the 4 °C
incubation, cells were washed once and then lysed to determine the
100% value for total bound virions after 1 h. Cell lysates were kept at
−20 °C until analysis by immunoblotting for β-actin or FIV capsid.
Immunoblot analysis of viral internalization assay
Proteins present in the cell lysates were separated on a 4–12% Bis–
Tris NuPAGE gel (Invitrogen) and transferred onto nitrocellulose. FIV
Capsid was detected by incubating with polyclonal anti-FIV antibody
(1:5000) overnight at 4 °C and with secondary peroxidase-conjugated
goat anti-feline antiserum (1:20,000; Amersham). β-actinwas detected
by incubating with a monoclonal anti-β-actin antibody conjugated to
peroxidase (1:10,000) for 2 h at room temperature. Membranes were
visualized using a Fujiﬁlm Image Reader LAS-3000 (Fujiﬁlm, Stamford,
CT) and using the chemiluminescence method according to the
manufacturer's protocol (Pierce). Data was analyzed and quantiﬁed
using the Fujiﬁlm Multi Gauge V2.3 program (Fujiﬁlm, Stamford, CT).
The capsid signal was normalized for actin levels and data are reported
as the ratio of the FIV signal in the Axl knock down cells divided by the
FIV signal in the cells transfected with an irrelevant RNA.
Viral transduction of AXL RNAi transfected cells with thermolysin-treated
virus
SNB-19 cells were transfected with AXL RNAi as described above.
Twenty-four h after transfection, cells were plated in a 48-well format
at a concentration of 3.5×104 cells per well. FIV/β-gal pseudovirions
bearing full-length ZEBOV-GP were treated for 5 min at 37 °C with 0.1
mg/ml of thermolysin (Sigma-Aldrich). Virus was then treated with
5mM EDTA for 5 min at room temperature to neutralize the
thermolysin. Thermolysin-treated or mock-treated virus was added
to transfected cells at 48 h following transfection. Six h after the
addition of thermolysin-treated virus, the virus was removed, media
refreshed, and cells incubated for an additional 48 h at 37 °C. At the
termination of the experiment, cells were ﬁxed in PBS with 3.7%
93M.A. Brindley et al. / Virology 415 (2011) 83–94formalin and evaluated for β-gal activity using the substrate 5-bromo-
4-chloro-3-indolyl-β-D-galactopyranoside. The number of β-gal-
positive cells was enumerated by microscopic visual inspection. The
ﬁndings are shown as the number of transduced cells found in each
treatment divided by the number of cells transduced by the untreated
full-length ZEBOV-GP control. The numbers in parenthesis represent
the effect of AXL RNAi treatment on transduction relative to the
respective control.Membrane fusion assay
SNB-19 cells were seeded at 3×104 cells per well in a 96-well plate
and incubated with 20 μg/ml (1:20) of goat anti-Axl antisera or
normal goat sera for 1 h at 4 °C. Cells were shifted to 37 °C and
incubated with 50 μl of Src-β-lactamase containing ZEBOV-GP ΔO
VLPs per well. After 12 h, VLPs within the media were removed and
0.1 mM CCF2-AM substrate was added to each well diluted in 100 μl
DMEM according to manufacturer's protocol (Invitrogen). Positive
controls for the β-lactamase assay included pCMV-src-β-lactamase
transfected and blue ﬂuorescent protein (BFP) transfected cells. The
plate was covered and incubated at room temperature for 2 h away
from direct sunlight. After 2 h, the cells were trypsinized with 0.05%
trypsin-EDTA (50 μl per well) and resuspended in a total volume of
100 μl (50 μl trypsin+50 μl DMEM). Blue/green ﬂuorescence was
quantiﬁed in the cells using a three laser FACS Aria (Becton Dickinson)
equipped with a 407 violet, a 488 blue, and a 633 red laser. Blue and
green ﬂuorescence was measured separately with emission ﬁlters
450/40 nm and 530/30 nm, respectively. The background blue
ﬂuorescence of untreated, CCF2-AM loaded control cells was
subtracted as autoﬂuorescence. Blue ﬂuorescence was expressed as
percentage blue cells in the population.Confocal microscopy
SNB-19 cells (3.5×104 cells) were plated on collagen-coated
coverslips and incubated overnight at 37 °C to allow cell adherence.
Cells were incubated with ZEBOV-GP ΔO or VSV-G FIV pseudovirions
(MOI=250) at 4 °C for 1 h. Unbound virus was removed, cells were
washed once in 1× PBS, and cells were shifted to 37 °C in pre-warmed
media for the indicated times. At the indicated time, cells were ﬁxed in
2% paraformaldehyde and not permeabilized or permeabilized with
0.2% Triton X-100. Virus (green) was detected with anti-FIV
monoclonal antibody (1:50) and Alexa Fluor 488 chicken α-mouse
(1:200; Invitrogen). Axl (red) was detected with anti-human Axl
polyclonal antibody (1:150) and Alexa Fluor 568 donkey α-goat
(1:200; Invitrogen). Microscopy was performed on a Nikon 801
confocal microscope with the gain set at the beginning of data
collection and not subsequently changed.Statistical analysis
Studies were performed at least three independent times except
where noted in the ﬁgure legends. Means and standard errors of the
mean are shown. Student's t-test was used to generate a p value to
evaluate the statistical differences between treatments, utilizing the
two-tailed distribution and two sample equal-variance conditions.
Signiﬁcance of the correlation ﬁndings in the NCI-60 screen was
assessed by performing a linear correlation and regression and
determining the p value from the two-tailed distribution. A signiﬁcant
differencewas determined by a p value of b0.05 and level of signiﬁcance
was noted in each ﬁgure. If the p value was N0.05, the data were not
considered statistically signiﬁcantly different.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2011.04.002.Acknowledgments
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